Helena Aicher

489 total citations
21 papers, 274 citations indexed

About

Helena Aicher is a scholar working on Clinical Psychology, Organic Chemistry and Nutrition and Dietetics. According to data from OpenAlex, Helena Aicher has authored 21 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Psychology, 12 papers in Organic Chemistry and 8 papers in Nutrition and Dietetics. Recurrent topics in Helena Aicher's work include Psychedelics and Drug Studies (19 papers), Chemical synthesis and alkaloids (12 papers) and Biochemical Analysis and Sensing Techniques (8 papers). Helena Aicher is often cited by papers focused on Psychedelics and Drug Studies (19 papers), Chemical synthesis and alkaloids (12 papers) and Biochemical Analysis and Sensing Techniques (8 papers). Helena Aicher collaborates with scholars based in Switzerland, Germany and United States. Helena Aicher's co-authors include Milan Scheidegger, Erich Seifritz, Peter Gasser, Rainer Kraehenmann, Franz X. Vollenweider, Oliver G. Bosch, Thomas Pokorny, Katrin H. Preller, Dan Pokorný and Ansgar Rougemont-Bücking and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Cellular and Molecular Life Sciences.

In The Last Decade

Helena Aicher

18 papers receiving 259 citations

Peers

Helena Aicher

CMN

PHARM

Taylor Lyons United Kingdom

Simon Ruffell United Kingdom

Raphael Underwood United Kingdom

Alba Franquesa Spain

Broc A. Pagni United States

Federico Zamberlán Argentina

Michael P. Bremmer United States

Rotem Petranker Canada

Erwin Krediet Netherlands

Luke T. J. Williams United Kingdom

Taylor Lyons United Kingdom

Helena Aicher

272 ×1.1

145 ×1.0

124 ×1.5

CMN

46 ×0.8

25 ×0.8

PHARM

Citations per year, relative to Helena Aicher Helena Aicher (= 1×) peers Taylor Lyons

Countries citing papers authored by Helena Aicher

Since Specialization

Citations

This map shows the geographic impact of Helena Aicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Aicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Aicher more than expected).

Fields of papers citing papers by Helena Aicher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Aicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Aicher. The network helps show where Helena Aicher may publish in the future.

Co-authorship network of co-authors of Helena Aicher

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Aicher. A scholar is included among the top collaborators of Helena Aicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Aicher. Helena Aicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aicher, Helena, Philippe Müller, Maxim Puchkov, et al.. (2025). Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study. Biomedicine & Pharmacotherapy. 184. 117908–117908. 3 indexed citations

Liechti, Matthias E., et al.. (2025). Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program. Neuroscience Applied. 4. 105525–105525. 2 indexed citations

Aicher, Helena, Michael Kometer, Michael J. Mueller, et al.. (2025). Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces. NeuroImage. 313. 121247–121247.

Aicher, Helena, et al.. (2025). The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies. Translational Psychiatry. 15(1). 401–401.

Aicher, Helena, Felix Müller, & Peter Gasser. (2025). Further education in psychedelic-assisted therapy – experiences from Switzerland. BMC Medical Education. 25(1). 341–341. 3 indexed citations

Aicher, Helena, Yasmin Schmid, & Peter Gasser. (2024). Psychedelika-assistierte Psychotherapie. 69(2). 98–106. 10 indexed citations

Perkins, Daniel, Jerome Sarris, Helena Aicher, et al.. (2024). Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset. Journal of Psychoactive Drugs. 58(1). 63–74. 1 indexed citations

Aicher, Helena, Michael J. Mueller, Dario Dornbierer, et al.. (2024). Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. Frontiers in Psychiatry. 14. 1302559–1302559. 18 indexed citations

Aicher, Helena & Peter Gasser. (2024). Weiterbildung in Psychedelika-assistierter Therapie – Erfahrungen aus der Schweiz. 69(2). 107–114. 3 indexed citations

10.

Aicher, Helena, et al.. (2024). Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors. Cellular and Molecular Life Sciences. 81(1). 395–395. 10 indexed citations

11.

Aicher, Helena, et al.. (2024). Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat. Journal of Psychopharmacology. 38(10). 897–910. 4 indexed citations

12.

Aicher, Helena & Peter Gasser. (2024). Treatment Recommendations for Psychedelic-assisted Therapy. 8 indexed citations

13.

Ehrenkranz, Rebecca, Sandeep M. Nayak, Helena Aicher, et al.. (2024). Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression. SHILAP Revista de lepidopterología. 3(2). 215–234. 8 indexed citations

14.

Aicher, Helena, Max Wolff, & Uwe Herwig. (2024). Psychedelic therapy – refining the claim of a paradigm shift. International Review of Psychiatry. 36(8). 920–927. 2 indexed citations

15.

Mueller, Marcus, Helena Aicher, Dario Dornbierer, et al.. (2024). Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial. The International Journal of Neuropsychopharmacology. 28(1). 3 indexed citations

16.

Herwig, Uwe, Mihai Avram, Stefan Borgwardt, & Helena Aicher. (2024). Neurobiologie und Wirkmodelle zu Psychedelika. Nervenheilkunde. 43(6). 340–349. 1 indexed citations

17.

Dornbierer, Dario, Helena Aicher, Michael J. Mueller, et al.. (2023). Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine. Frontiers in Pharmacology. 14. 1246892–1246892. 15 indexed citations

18.

Sarris, Jerome, Daniel Perkins, Lachlan Cribb, et al.. (2021). Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers. Journal of Affective Disorders Reports. 4. 100098–100098. 45 indexed citations

19.

Jungaberle, Henrik, et al.. (2018). Positive psychology in the investigation of psychedelics and entactogens: A critical review. Neuropharmacology. 142. 179–199. 53 indexed citations

20.

Kraehenmann, Rainer, Dan Pokorný, Helena Aicher, et al.. (2017). LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation. Frontiers in Pharmacology. 8. 814–814. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact